82
48
Growth Score 82 in past quarter
-8 pts
Heat Score 48 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
559698
Lek d.d. develops, produces, and distributes generics pharmaceuticals for customers worldwide.
- Alja Oblak: Biologics Technical Development & Manufacturing
Helena Trnovec: Scientist
About the Company
Lek is a part of Sandoz, the generic division of Novartis, and a pioneer in the field of biosimilars and the second-largest generic pharmaceutical company in the world. Novartis is the leading provider of medicines in Slovenia, where further development is planned, as well.
